FR2490631A1 - Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique - Google Patents

Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique Download PDF

Info

Publication number
FR2490631A1
FR2490631A1 FR8020477A FR8020477A FR2490631A1 FR 2490631 A1 FR2490631 A1 FR 2490631A1 FR 8020477 A FR8020477 A FR 8020477A FR 8020477 A FR8020477 A FR 8020477A FR 2490631 A1 FR2490631 A1 FR 2490631A1
Authority
FR
France
Prior art keywords
acid
composition according
triglycerides
vitamin
linolenic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8020477A
Other languages
English (en)
French (fr)
Other versions
FR2490631B1 (esLanguage
Inventor
Francois Mendy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR8020477A priority Critical patent/FR2490631A1/fr
Priority to US06/302,624 priority patent/US4407821A/en
Priority to NL8104348A priority patent/NL8104348A/nl
Priority to GB8128943A priority patent/GB2084172B/en
Priority to JP56149664A priority patent/JPS5791915A/ja
Priority to DE19813138088 priority patent/DE3138088A1/de
Priority to FR8119321A priority patent/FR2514346A2/fr
Publication of FR2490631A1 publication Critical patent/FR2490631A1/fr
Application granted granted Critical
Publication of FR2490631B1 publication Critical patent/FR2490631B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
FR8020477A 1980-09-24 1980-09-24 Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique Granted FR2490631A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR8020477A FR2490631A1 (fr) 1980-09-24 1980-09-24 Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US06/302,624 US4407821A (en) 1980-09-24 1981-09-15 Lipidic compositions for use in dietetics, reanimation and therapeutics
NL8104348A NL8104348A (nl) 1980-09-24 1981-09-22 Nieuwe lipidensamenstellingen geschikt voor toepassing op dieetgebied, reanimeringsgebied en therapeutisch gebied.
GB8128943A GB2084172B (en) 1980-09-24 1981-09-24 Lipid compositions useful in dietetics
JP56149664A JPS5791915A (en) 1980-09-24 1981-09-24 Novel lipid composition useful for dietetics, resuscitation and treatment
DE19813138088 DE3138088A1 (de) 1980-09-24 1981-09-24 Lipidzusammensetzungen fuer diaetetische und therapeutische zwecke
FR8119321A FR2514346A2 (fr) 1980-09-24 1981-10-14 Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8020477A FR2490631A1 (fr) 1980-09-24 1980-09-24 Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique

Publications (2)

Publication Number Publication Date
FR2490631A1 true FR2490631A1 (fr) 1982-03-26
FR2490631B1 FR2490631B1 (esLanguage) 1983-11-18

Family

ID=9246241

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8020477A Granted FR2490631A1 (fr) 1980-09-24 1980-09-24 Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique

Country Status (6)

Country Link
US (1) US4407821A (esLanguage)
JP (1) JPS5791915A (esLanguage)
DE (1) DE3138088A1 (esLanguage)
FR (1) FR2490631A1 (esLanguage)
GB (1) GB2084172B (esLanguage)
NL (1) NL8104348A (esLanguage)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324748A (en) * 1981-07-14 1994-06-28 Efamol Limited Method for enhancement of 1-series PG production
EP0092076B1 (fr) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Composition lipidique destinée à l'alimentation orale, entérale ou parentérale
CA1225597A (en) * 1982-09-22 1987-08-18 Jakobus Booyens Prophylactic substance or composition
JPS60130519A (ja) * 1983-12-16 1985-07-12 Terumo Corp 脂肪輸液剤
JPS60222418A (ja) * 1984-04-17 1985-11-07 Terumo Corp 抗動脈硬化症製剤
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
WO1985003002A1 (en) * 1984-01-16 1985-07-18 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
GB8408974D0 (en) * 1984-04-06 1984-05-16 Efamol Ltd Food production
CH663951A5 (fr) * 1984-10-10 1988-01-29 Nestle Sa Procede d'enrichissement selectif en acides gras polyinsatures d'un melange contenant des acides gras fractions enrichies obtenues et compositions les contenant.
FR2574089B1 (fr) * 1984-12-03 1987-04-10 Inst Nat Sante Rech Med Procede de production d'acides gras, en particulier d'acide g-linoleique a partir de tetrahymena, produits obtenus et preparation medicamenteuse ou alimentaire contenant de l'acide g-linolenique ou ses derives en tant qu'agent anti-agregation plaquettaire
JPH078803B2 (ja) * 1986-04-25 1995-02-01 雪印乳業株式会社 低コレステロール血症治療剤
EP0267965A1 (en) * 1986-05-23 1988-05-25 NAKANISHI, Michio Composition containing linolenic acid compound
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
IT1214018B (it) * 1987-11-26 1990-01-05 Giuliano Roberto Crema Estensione dell'uso di un prodotto farmaceutico alimentare curativo
US4999380A (en) * 1988-10-18 1991-03-12 Nestec S.A. Treatment of lipoprotein disorders associated with cholesterol metabolism
US5234952A (en) * 1988-12-23 1993-08-10 Nestec S.A. Reduction of thrombogenicity with lipids of blackcurrant seed
CH676909A5 (esLanguage) * 1988-12-23 1991-03-28 Nestle Sa
US5000975A (en) * 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
US5196198A (en) * 1989-06-02 1993-03-23 Abbott Laboratories Parenteral nutrition product
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
NL9301251A (nl) * 1993-07-15 1995-02-01 Gerard Maria Eugene Janssen Middel ter toevoeging aan een sportdrank en het vormen van een nieuw soort sportdrank voor sportprestatieverbetering.
DE4405545A1 (de) * 1994-02-22 1995-08-31 Dietl Hans Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation
US6303662B1 (en) * 1997-04-18 2001-10-16 Taisho Pharmaceutical Co., Ltd. Microemulsion
AU1911999A (en) * 1997-12-12 1999-06-28 Penn State Research Foundation, The Methods and compositions for treating diabetes
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
US6835408B2 (en) 1998-11-13 2004-12-28 The Nisshin Oillio Group, Ltd. Oil or fat composition
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
ES2323940T3 (es) 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US6809115B2 (en) 2000-09-21 2004-10-26 Nutrition 21, Inc. Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
CA2446059C (en) * 2001-05-14 2010-03-23 Martek Biosciences Corporation Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
JP2004536059A (ja) * 2001-05-14 2004-12-02 マーテック バイオサイエンシズ ボールダー コーポレーション 微生物、遺伝的に改変された植物種子および海洋生物由来のω−３および／またはω−６高度不飽和脂肪酸を含有する極性脂質の豊富な画分の生成および使用
AU2003211636A1 (en) * 2002-03-04 2003-09-16 The Nisshin Oillio Group, Ltd Body temperature elevating agents
JP2004075653A (ja) * 2002-06-19 2004-03-11 Nisshin Oillio Ltd 体脂肪分解促進剤および飲食物
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US20060189545A1 (en) * 2003-03-06 2006-08-24 Henderson Samuel T Novel chemical entities and methods for their use in treatment of metabolic disorders
FR2860720A1 (fr) * 2003-10-09 2005-04-15 Jean Pascal Conduzorgues Nouvelles compositions pharmaceutiques pour traiter la xerostomie et maladies similaires
US20050096383A1 (en) * 2003-11-04 2005-05-05 Ingvar Olafsson Method and composition for oral cavity hygiene
US7175862B2 (en) * 2004-01-28 2007-02-13 Access Business Group International Llc Method of preparing kakadu plum powder
EP1656934A1 (en) * 2004-11-12 2006-05-17 Cognis IP Management GmbH Use of physiologically active fatty acids for treating lipodystrophy
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
WO2007001883A2 (en) * 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
MX2008007517A (es) * 2005-12-15 2009-03-04 Nestec Sa Composiciones y metodos para preservar la funcion cerebral.
PT2500017T (pt) * 2006-04-03 2017-11-14 Accera Inc Utilização de compostos cetogénicos para tratamento de comprometimento da memória associado à idade
BRPI0811052A2 (pt) 2007-04-12 2015-01-27 Univ Minnesota Composições de proteção de isquemia/reperfusão e métodos de uso.
US20080318909A1 (en) * 2007-06-14 2008-12-25 Sparagna Genevieve C Use Of Linoleic Compounds Against Heart Failure
PT2179284T (pt) 2007-07-31 2016-12-30 Accera Inc Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida
JP5428107B2 (ja) * 2007-11-27 2014-02-26 出光興産株式会社 扁平上皮癌細胞増殖抑制剤
CN102105071A (zh) * 2008-07-03 2011-06-22 艾克塞拉公司 用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物
US8105809B2 (en) * 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US10307398B2 (en) 2016-09-20 2019-06-04 Regents Of The University Of Minnesota Resuscitation composition and methods of making and using
AU2018440781A1 (en) * 2018-09-11 2021-04-22 Parapharm Development Limited Capsule, tablet or pill

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2749492A1 (de) * 1976-11-04 1978-05-11 Bio Oil Res Antithrombosemittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450819A (en) * 1965-07-12 1969-06-17 Drew Chem Corp Synthetic therapeutic fat
GB1446431A (en) 1972-04-20 1976-08-18 Williams J Nutritional supplement
FR2197605A1 (en) 1972-09-06 1974-03-29 Williams John Foodstuff or skin nutrient to combat cholesterolaemia - contains arachidonic acid or gamma linolenic acid or esters and salts thereof
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2749492A1 (de) * 1976-11-04 1978-05-11 Bio Oil Res Antithrombosemittel

Also Published As

Publication number Publication date
NL8104348A (nl) 1982-04-16
JPH044358B2 (esLanguage) 1992-01-28
GB2084172A (en) 1982-04-07
FR2490631B1 (esLanguage) 1983-11-18
DE3138088A1 (de) 1982-05-06
JPS5791915A (en) 1982-06-08
US4407821A (en) 1983-10-04
GB2084172B (en) 1984-05-10
DE3138088C2 (esLanguage) 1992-07-30

Similar Documents

Publication Publication Date Title
FR2490631A1 (fr) Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
EP0092076B1 (fr) Composition lipidique destinée à l'alimentation orale, entérale ou parentérale
CA2411368C (en) Therapeutic combinations of fatty acids
US5656667A (en) Fatty acid composition
FR2553662A1 (fr) Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang
AU2001274276A1 (en) Therapeutic combinations of fatty acids
FR2955459A1 (fr) Composition huileuse riche en monoglycerides de dha
EP0719152A1 (fr) Nouvelles utilisations d'un complexe a base de phospholipides cerebraux en therapeutique et dans l'alimentation
JP2006083136A (ja) ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
AU636582B2 (en) Triglycerides, nutritional composition comprising such triglycerides, and use of the nutritional composition for nutrition
JPH06511384A (ja) ヒトおよび動物用の栄養剤
JP2005132758A (ja) 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US6228367B1 (en) Food supplement formulation
JPH04504257A (ja) 非経口栄養摂取用医薬脂質組成物
RU2752298C1 (ru) Биологически активная добавка к пище для нормализации липидного обмена и способ её применения
WO2003097033A2 (fr) Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations
JP2025529061A (ja) セトレイン酸組成物
FR2865353A1 (fr) Nouveaux complements dietetiques ou alimentaires a base d'acide gras insature et leurs utilisation
FR2514346A2 (fr) Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
HK1050486B (en) Therapeutic combinations of fatty acids

Legal Events

Date Code Title Description
ST Notification of lapse